Search results
Results From The WOW.Com Content Network
A central securities depository (CSD) is a specialized financial market infrastructure organization holding securities like shares, either in certificated or uncertificated (dematerialized) form, allowing ownership to be easily transferred through a book entry rather than by a transfer of physical certificates.
Central securities depositories of India (4 P) Pages in category "Central securities depositories" The following 23 pages are in this category, out of 23 total.
Cede and Company (also known as Cede and Co. or Cede & Co.) is a specialist United States financial institution that processes transfers of stock certificates on behalf of Depository Trust Company, the central securities depository used by the United States National Market System, which includes the New York Stock Exchange, and Nasdaq. [1]
Brussels head office of Euroclear, a major international financial market infrastructure. Financial market infrastructure refers to systems and entities involved in clearing, settlement, and the recording of payments, securities, derivatives, and other financial transactions. [1]
Central securities depositories (1 C, 23 P) Pages in category "Securities clearing and depository institutions" The following 28 pages are in this category, out of 28 total.
In February 1999, CDSL received certificate of commencement of business from Securities and Exchange Board of India (SEBI). [7] On 30 June 2017, CDSL was listed on the National Stock Exchange (NSE) through initial public offering (IPO) [8] making it the first depository in Asia-Pacific region and only the second depository in the world to get listed.
CSDC was set up on March 30, 2001. [2] In September 2001, Shanghai Securities Central Depository and Clearing Corporation and Shenzhen Securities Depository Corporation, two corporations which were in responsible for depository and clearing services of Shanghai Stock Exchange and Shenzhen Stock Exchange, were merged into the CSDC. [3]
In August 2020, the U.S. Food and Drug Administration (FDA) became aware of nitrosamine impurities in certain samples of rifampin. [61] The FDA and manufacturers are investigating the origin of these impurities in rifampin, and the agency is developing testing methods for regulators and industry to detect the 1-methyl-4-nitrosopiperazine (MNP ...